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Abstract 
Purpose: To investigate the inhibitory activity of crude methanol extract, fractions and two pure 
compounds from Rhus tripartita stem cyclooxygenases (COX-1 and COX-2) and acetylcholinesterase 
(AChE); also, to evaluate their antioxidant properties in in-vitro assays.  
Methods: R. tripartita extract and fractions were examined as inhibitors of COX-1 and COX-2 and 
AChE. Their antioxidant properties were also evaluated using various antioxidant tests, including free 
radical scavenging, nitric oxide, and total antioxidant capacity.  
Results: Ethyl acetate fraction (RT2), aqueous fraction (RT4), subfraction RT2-II, and subfraction RT2-
III had a potent inhibitory effect on AChE with low IC50 values. At the same time, a subfraction (RT2-III) 
was an effective COX-2 inhibitor (94.5 % at 10 µg/mL) followed by ethyl acetate fraction (RT2; 79.39 %), 
aqueous fraction (RT4; 70 %), total extract (RT; 66.18 %), subfraction RT2-III (64.08 %), compound 5 
(epicatechin; 61.25 %), compound 2 (taxifolin; 55.63 %), subfraction RT2-II (46.85 %), and butanol 
fraction (RT3; 40.80%). RT2, RT4, RT2-II, RT2-III, and compound 2 each showed 100 % inhibition at 20 
µg/mL. 
Conclusion: The ethyl acetate fraction (RT2), aqueous fraction (RT4) and subfractions RT2-II and RT2-
III are effective natural inhibitors of AChE. Subfraction RT2-III is the best COX-2 inhibitor, followed by 
ethyl acetate fraction RT2 and aqueous fraction (RT4). These bioactive materials can be considered 
natural COX-2 and AChE inhibitors 
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The search for innovative pharmacologically 
active natural agents for dealing with human 
diseases can lead to the discovery of several 
clinically valuable natural drugs.  Many diseases 
like rheumatoid arthritis, chronic asthma, 
multiples sclerosis, inflammatory bowel disease, 
psoriasis and neuro-inflammatory diseases are 
related to inflammation [1]. Inflammation is a 
mandatory host defense reaction to infection or 
injury [2]. It is accepted that both the beneficial 
and detrimental effects of nonsteroid anti-
inflammatory drugs (NSAIDs) are attributable to 
their ability to inhibit prostaglandin synthesis 
through direct blockage of cyclooxygenase 2 
(COX-2). Of the two isoforms of COX, COX-1 is 
a constitutively expressed form required for 
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common physiological functions, and COX-2 is 
induced only as a part of inflammatory processes 
[3]. Therefore, a selective COX-2 inhibitor can 
avoid toxic effects on cellular physiological 
functions. The cascades of an inflammatory 
response are known to be the main risk factor of 
neurodegenerative diseases including AD, which 
is a devastating disorder manifesting itself in 
deterioration of memory and cognition, 
impairments in execution of activities of daily 
living, and many behavioral and neuropsychiatric 
aberrations [4]. Rhus species are widely used in 
both modern and traditional medicine due to their 
high concentration of polyphenols, flavonoids, 
proanthocyanidins, and other phytochemicals. A 
Rhus extract was reported to serve as an 
antimicrobial, antitumorigenic, antioxidant, 
hypoglycemic, and anticonvulsant agent [5]. 
Recent studies on Rhus tripartita confirmed the 
abundant presence of proanthocyanidins in a 
root cortex extract [6]. Proanthocyanidins 
isolated from different plants were reported as 
potent antioxidant, antiviral, and anti-HIV agents 
[7].  
 
The present study was designed to evaluate an 
R. tripartita extract, its fractions, and pure 
compounds as anti-inflammatory agents acting 
against COX-1 and COX-2, and to test them on 
acetylcholinesterase activity in addition to 






Rhus tripartita (Ucria) Grande (Anacardiaceae) 
was collected from Hail area, Kingdom of Saudi 
Arabia in April 2013.  Hail is located in the North-
Western of Kingdom of Saudi Arabia at latitude 
27º31' North and longitude 41º43' East. The 
temperature is between 9.6-33.0 ºC and an 
annual rainfall of about 29.4 mm. The average 
relative humidity is 90-100%. Moreover, elevation 
heights above sea level about 1009.1 m. The 
plant was identified by Dr. Mohamed Yousuf. A 
voucher specimen (SY202/2013) was deposited 
in the Herbarium of the College of Pharmacy, 





6-sulfonic) acid diammonium salt, phenazine 
methosulphate (PMS)-nicotinamide adenine 
dinucleotide (NADH), nitroblue tetrazolium 
(NBT), Tris-HCl buffer, Greiss reagent, sodium 
nitroprusside ascorbic acid (Vc), butylated 
hydroxytoluene (BHT), leuco-2,7-
dichlorofluorescein diacetate, hematin, arachi-
donic acid, Tris-buffer, cyclooxygenase enzyme 
(COX-1 from sheep, EC 1.14.99.1 or COX-2), 
acetylcholinesterase (EC No. 3.1.1.7) type VI-S 
(from electric eel), eserine hemisulfate salt, 
acetylthiocholine iodide, and dithiobis 
(nitrobenzoic) acid (DTNB) were purchased from 
Sigma-Aldrich, USA 
 
Extraction of plant materials and isolation of 
pure compounds 
 
Air-dried powdered stem (1000 g) were 
exhaustively extracted with 80 % methanol (3 x 
3000 mL) at room temperature. After filtration 
and evaporation using reduced pressure at 35 
°C, the residual aqueous solution (RT) was 
partitioned with methylene chloride (CH2Cl2; 
fraction RT1), ethyl acetate (EtOAc; fraction 
RT2), or normal butanol (n-BuOH; fraction RT3) 
(4  400.mL each). The organic fractions were 
concentrated using reduced pressure, and the 
aqueous residual layer was lyophilized (RT4). 
The EtOAc fraction (RT2; 20 g) was separated 
on a Sephadex LH-20 column (Pharmacia; 100 x 
4 cm) using EtOH as the mobile phase. Fractions 
50 mL each were collected and analyzed by thin-
layer chromatography (TLC; Silica gel 60 F254, 
0.2 mm, Merck) using the upper layer of the 
mixture EtOAc-HOAc-HCOOH-H2O 
(30:0.8:1.2:8) as a mobile phase.  
 
The spots were detected by UV light (254 and 
366 nm) before and after spraying with Neu’s 
spray reagent (reagent a) and vanillin H2SO4 
(reagent b).  Fractions 20-35, which gave 
positive reaction with reagent a and developed a 
purple-red color with reagent b, were combined 
(RT2-I).  Fractions 36-43 which gave a yellow or 
orange color with reagent a, were combined in 
one group (RT2- II) and Fraction 44-69, fraction 
70-85 and 86-102 which developed a purple-red 
color with reagent b, were collected together in 
one group (RT2- III), (RT2- IV) and (RT2- VI). 
 
Column chromatography of sub-fractions RT2-I 
on Sephadex LH-20 using methanol as mobile 
phase, gave compounds 1 and 2. Sub-fraction 
RT2-II was subjected to Sephadex LH-20 using 
methanol as mobile phase to give compounds 3.  
Sub-fraction R2-III was subjected to C18-
reverse-phase columns with MeOH-H2O (6:4) as 
eluent to give compounds 4 and 5. Sub fraction 
(R2- IV), (R2- V) and (R2- VI) are kept for further 
investigation. 
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Determination of inhibitory activity on 
cyclooxygenases  
 
The method of Larsen et al [8] was used for 
testing of natural or synthetic materials against 
cyclooxygenase 2. The main idea behind this 
method is oxidation of leuco-2,7-
dichlorofluorescein in the presence of phenol to 
produce hydrogen peroxide. This method is 
considered a sensitive spectrophotometric assay 
for the PGH synthesis activity. Leuco-2, 7-
dichlorofluorescein di acetate (L-DCF) was 
hydrolyzed in sodium hydroxide for 10 min and 
then the alkaline media was neutralized using 
hydrochloric acid and finally the reaction micture 
was diluted with Tris-buffer. The tested enzyme 
(COX-1 or COX-2) was diluted in Tris-buffer in 
order that a known aliquot gave an absorbance 
change of 0.05/min in the test reaction. The 
diluted enzyme was incubated with samples or 
equivalent volume of methanol in presence of 
hematin. L-DCF, arachidonic acid and phenol 
were added to enzyme mixture to begin the 
reaction. The reaction was recorded 
spectrophotometrically (Jasco, serial No. 
C317961148, Japan) over 1 min at 502 nm. A 
blank reaction mixture was recorded for each 
sample to avoid any non-enzymatic activity 
attributed to the test sample and another reaction 
for reference compound, Celecoxib, was also 
monitored at the same time at the same 
concentration of samples.  
 
Acetylcholinesterase inhibition determination 
 
Enzymatic activity was analyzed using an 
adaptation of the method of Ingkaninan [9]. 
Namely, 500 µL of the DTNB "3 mM", 100 µL of 
acetylthiocholine iodide (15 mM), 275 µL of Tris–
HCl buffer (50 mM, pH 8), and 100 µL of each 
sample at different concentrations (2.5, 5, 10, 20, 
or 40 µg/mL) was dissolved in ethyl alcohol 
(HPLC grade) and was added to a 1-mL cuvette 
then was used as a blank. In the reaction 
cuvette, 25 µL of Tris-HCl buffer was replaced by 
the same volume of an enzyme solution 
containing 0.28 U mL−1. The color developed 
was monitored for 5 min at 405 nm. The percent 
inhibition was calculated using the formula: 
{(control absorbance − sample 
absorbance)/control absorbance} x 100. The IC50 
was calculated by log-probit analysis. Eserine 
served as a positive control [10]. 
 
Nitric oxide radical scavenging activity assay 
 
The test samples at 2.5, 5, 10, 20, and 40 µg/mL 
were tested as a nitric oxide radical scavenger 
using a sodium nitroprusside (SNP) system 
generating NO•. Nitric oxide radicals (NO•) were 
generated from SNP in the aqueous solution at 
physiological pH, and this radical reacts with 
oxygen to produce nitrite ions which were 
detected by the Greiss reagent [11]. Two 
milliliters of the above reaction mixture containing 
tested fractions or standard compounds and SNP 
(final concentration, 10 mM) in phosphate 
buffered saline (pH 7.4) were incubated at 25 °C 
for 150 min. One milliliter of the Greiss reagent 
was added to 1 mL of the incubated mixture, and 
then absorbance was measured at 540 nm 
against a blank solution. The blank solution 
contained all chemicals and reagents without 
samples and was incubated for the same period.  
 
Free radical scavenging activity assay 
 
Free radical scavenging activity was measured 
using method of Yamaguchi et al [12]. In brief 0.1 
mM of DPPH solution was added to 3 mL of each 
sample or standards at 2.5, 5, 10, 20 and 40 
µgmL-1. The reaction mixture was shaken and 
allowed to stand at room temperature for 30 min. 
The absorbance was measured at 517 nm. 
DPPH• radical scavenging activity (D) was 
calculated in the reaction medium as in Eq 1.  
 
D (%) = 100 – {(A0 - A1)/A0)}100 …………. (1) 
 
A0 is the absorbance of the control reaction, and 
A1 is the absorbance in the presence of the 
sample. 
 
Superoxide anion-scavenging activity 
 
This activity was isolated by the method of Gülçin 
et al [13], where superoxide radicals are 
generated in a phenazine methosulphate (PMS)–
nicotinamide adenine dinucleotide (NADH) 
system via oxidation of NADH; the superoxide 
radicals are assayed by the reduction of NBT. 
Superoxide radicals were generated in Tris-HCl 
buffer (16 mM, pH 8.0, 3 mL) containing NBT (50 
µM, 1 mL), NADH (78 µM, 1 mL), and fractions 
or isolated compounds to be assayed (1 mL) at 
different concentrations. The reaction was 
started by addition of a phenazine methosulfate 
(PMS) solution (10 µM, 1 mL). The reaction 
mixture was incubated at 25 °C for 5 min, and 
absorbance (560 nm) was measured. 
Decreasing absorbance indicated increasing 
superoxide anion-scavenging activity. The 
percentage inhibition of superoxide anion 
production was calculated using Eq 2:  
 
Inhibition (%) = {(A0 - A1)/A0}100 …………. (2) 
 
where A0 is the absorbance of the control, and A1 
is the absorbance of the tested materials. 
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Total antioxidant activity 
 
This capacity of the tested materials was 
measured using an 2,2-azino-bis(3-
ethylbenzthiazoline-6-sulfonic acid) (ABTS) 
peroxidase system as explained by Miller et al. 
[14]. Peroxidase (4.4 U/mL) was kept in the dark 
with hydrogen peroxide (50 μM) and ABTS 
(diammonium salt, 100 μM) for 60 min, and the 
absorbance of the developed color was 
determined for each sample, standard, and 
control at 734 nm. Total antioxidant capacity (C) 
was then calculated as in Eq 3.  
 
C (%) = {1 - (As/Ac)}100 ……………..... (3) 
 
where As and Ac are the absorbance of test 




All data are expressed as mean ± standard 
deviation (SD). One-way analysis of variance 
was used for statistical evaluation of significant 
differences among multiple groups followed by a 
post hoc test: Tukey’s multiple-comparison test. 
Differences were considered significant at p < 





The crude methanol extract, different fractions, 
and two pure compounds as well as the standard 
compound, celecoxib, were screened for their 
possible inhibitory effect on cyclooxygenases 
(COX-1 and COX-2). All of the tested samples 
inhibited COX-2 in a concentration-dependent 
manner reaching 100 % in efficiency at the 
maximum concentration (40 µg/mL), whereas 
celecoxib reached 29.36 % efficiency at the 
same concentration (Figs. 1 and 2). Subfraction 
RT2-III showed the best COX-2 inhibition: 94.5 % 
inhibition at 10 µg/mL, followed by fraction RT2 
(79.39 %), fraction RT4 (70%), total extract RT 
(66.18 %), subfraction RT2-I (64.08 %), 
compound 5 (61.25 %), compound 2 (55.63 %), 
subfraction RT2-II (46.85 %), and then fraction 
RT3 (40.80 %). Fraction RT2, fraction RT4, 
subfraction RT2-II, subfraction RT2-III, and 
compound 2 each showed 100 % inhibition at 20 
µg/mL (Figs. 1 and 2). 
 
 
Figure 1: Inhibitory effects of Rhus tripartita stem fractions and celecoxibe on cyclooxygenase 2. Results are 




Figure 2: Inhibitory effect of Rhus tripartita stem fractions, compound 2 and 5 and a standard on cyclooxygenase 
2. Results are presented as mean ± SD (n = 3); p ≤ 0.05. Tests were performed at five concentrations (2.5, 5, 10, 
20 and 40 µgmL-1) 
Shahat et al 
Trop J Pharm Res, August 2016; 15(8): 1701  
 
On the other hand, the nine tested fractions 
showed weak inhibitory effect against 
cyclooxygenase-1. The inhibitory effect of leuco-
dichlorofluorescein (L-DCF) oxidation in the 
presence of phenol by the hydroperoxide formed 
in the COX-1 reaction increased with the 
increasing concentration of a tested fraction. The 
maximal inhibitory effect on COX-1 was 
produced by compound 5 (43.34 %) followed by 
Rt2-II (32.73 %), and compound 2 (23.81 %), 
while fractions RT2-III showed the same 
inhibitory effect as that of celecoxib (17 %; Fig. 
3). The oxidation was only weakly suppressed by 
fractions RT (8.17 %), RT2 (9.01 %), or Rt2-I. 
 
The Rhus fractions and isolated compounds 
were also tested for their probable inhibitory 
effects in the in-vitro assay, against AChE. They 
inhibited acetylcholinesterase concentration-
dependently. Acetylcholinesterase significantly 
inhibits at 2.5 µg/mL when it was treated with 
Sub-fraction RT2-III (49.81 %) followed by 
fraction RT2 (42.56 %),  RT-4 (41 %) and then 
Sub-fraction RT2-I (33.14 %) while compound 5 
and compound 2 showed the weakest inhibitory 
effects (6.16 and 3.62 %, respectively Table, 1).  
Total extract (RT) and fraction RT3 showed the 
smallest suppressive effect toward acetylcholi-
nesterase at 2.5 µg mL-1 (16.72 % and 15.44 %, 
respectively). On the other hand, the enzyme 
was completely inhibited (100 %) when it was 
treated with fractions RT2 and Sub-fraction RT2-
III at 20 µg/mL, while the total extract RT, fraction 
RT2, fraction RT4 and Sub-fraction RT2-III at 40 
µg/mL Sub-fraction RT2-III, fraction RT2, RT4 
and Sub-fraction RT2-I were the potent inhibitor 
for acetylcholinesterase, they presented the 





Figure 3: The Inhibitory effect of Rhus tripartite stem fractions compound 5, compound 2, and the standard on 
Cyclooxygenase 1 activity. Results are presented as mean of triplicates ± S.D., p ≤ 0.05. Tests were performed 
at five concentrations (2.5, 5, 10, 20 and 40 µg mL-1) 
 
 
Figure 4: The inhibitory effects of Rhus tripartita stem fractions and the standard on     cyclooxygenase 1 activity. 
Results are presented as mean of triplicates ± S.D., p ≤ 0.05. Tests were performed at five concentration (2.5, 5, 
10, 20 and 40 µg mL-1) 
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 2.5 µg/mL 5 µg/mL 10 µg/mL 20 µg/mL 40 µg/mL IC50 
(µg/mL) 
RT 16.72±0.92a 39.11±1.24 64.22±1.52 92.03±2.06 100±1.01k 9.42 
RT2 42.56±1.13b 65.36±1.15 74.20±1.41f 100±2.10g 100±1.55k 4.10 
Rt3 15.44±1.24a 24.12±1.31d 33.8±1.19 42.23±2.00 h 55.25±1.07m 28.01 
RT4 41±0.98b 59.49±1.07 72.62±1.17f 95.29±1.33 100±1.00k 4.45 
RT2-I 33.14±1.15 42.42±1.02 57.42±1.03 65.89±1.27 86.77±2.03 6.26 
RT2-II 10.54±1.03 25.40±1.11d e 37.17±1.73 42.37±1.09 h 53.27±1.31m 33.32 
RT2-III 49.81±0.97a 71.44±2.01 89.15±1.45 100±2.08g 100±0.98k 3.42 
Comp. 2 
(Taxifolin) 
3.62±0.11 18.33±0.99 41.38±1.43 52.81±1.67 61.53±0.75 18.36 
Comp. 5 
(Epicatechin) 
6.16±0.13 26.33±1.61 e 46.77±1.64 60.23±1.88 71.16±0.85 15.78 
Eserine hemisulphate (positive 
control) 
IC50 = 0.03 µg/ mL 
Data are presented as mean ± SD (n = 3). Groups with the same letter have no significant difference between 
them. IC50 is concentration that reproduces 50 % inhibition 
 
Antioxidant properties of natural substances play 
an important role in defense mechanism or 
treating many diseases. Antioxidant properties 
were assessed in in-vitro methods. The total 
extract, fractions, and compounds scavenged 
nitric oxide radicals, DPPH radicals and 
superoxide anion radicals and they were more 
potent than tested reference compounds, vitamin 
C and BHT. Compound 2, subfraction RT2-I, and 
subfractions RT2-III and RT4 have a valuable 
nitric oxide radical-scavenging effect with low 
IC50 values (9.71, 10.08, 10.22, 11.46, and 12.96 
µg/mL, respectively), while the minimal recorded 
scavenging effect was shown by RT4. Fraction 
RT3 and subfraction RT2-II showed the second 
weakest scavenging action (22.22 and 20.71 
µg/mL; Table 2). On the other hand, DPPH 
radicals were significantly captured by R. 
tripartita fractions in the following order: 
subfraction RT2-I, total fraction RT, compound 5, 
fraction RT4, and subfraction RT2-III, with 
insignificant differences among them (Table 2). 
 
Superoxide anion radicals were trapped by R. 
tripartita fractions, and the crude stem extract 
turned out to have the minimal IC50 of 4.41 
µg/mL. Subfraction RT2-I, fractions RT4 and 
RT2, and compound 5 were alike in terms of 
quenching the SO2- radicals: they showed the 
same IC50 values with insignificant differences 
(IC50 ≈ 5 µg/mL). The long-lived ABTS•+ radical 
was strongly quenched by RT2 (IC50 = 8.33 
µg/mL) while RT3, subfraction RT2-II, and 
compound 5 showed nearly the same effect (IC50 
values were 12.31, 13.28, and 14.73 µg/mL, 
respectively). R. tripartita total extract had the 
same strength of the effect as vitamin C did, 
whereas subfraction RT2-III and compound 5 
mimicked the effect of BHT (35.19 and 30.49 
µg/mL, respectively). 
 
Table 2: Antioxidant properties of fractions and standards 
 
         Test 
 
Sample  









RT 12.96±1.20 6.48±0.97 4.41±1.08 46.29±1.88 
RT2 16.67±2.11 8.33±0.97 5.67±1.23 8.33±1.31 
RT3 22.22±1.56 11.11±1.75 7.56±1.43 12.31±1.86 
RT4 11.46±2.08 7.42±1.93 5.14±1.33 40.82±2.12 
RT2-I 10.08±1.84 6.23±1.08 5.00±0.99 38.63±1.78 
RT2-II 20.71±2.37 9.78±1.00 8.52±1.56 13.28±1.38 
RT2-III 10.22±2.74 7.46±1.91 4.48±0.98 35.19±2.14 
Comp. 2 (Taxifolin) 18.85±1.96 9.21±1.76 9.53±1.41 14.73±1.84 
Comp. 5 (Epicatechin) 9.71±1.58 6.97±1.88 5.83±1.51 30.49±2.13 
Vitamin C 53.83±2.00 41.51±1.99 52.32±2.34 45.81±1.33 
BHT 53.25±1.58 44.52±1.58 48.38±1.96 36.79±2.10 
Data are expressed as mean ± SD (n = 3). All recorded results revealed significant differences with vitamin C and 
BHT (p < 0.05). There is an insignificant difference between groups that have the same letter. IC50 values are the 
concentrations that produced a 50 % effect 
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NMR data of isolated compounds 
 
Gallocatechin (1)  
 
1H NMR (CD3OD): δ 6.41 (2 H, H-2', H-6'), 6.41 
(2 H, H-2', H-6'), 5.93 and 5.87 (2 H, H-6, H-8), 
4.55 (1 H, H-2), 4.53 (1 H, H-3), 2.84 (1 H, H-4a), 
2.80 (1 H, H-4b). 
 
13C NMR (CD3OD): δ 81.46 (C-2), 67.36 (C-3), 
26.62 (C-4), 155.44 (C-5), 94.8 (C-6), 156.4 (C-
7), 99.3 (C-8), 156.2 (C-9), 99.3 (C-10), 130.1 
(C-1'), 105.7 (C-2' and C- 6'), 145.4 (C-3' and C- 




1H NMR (CD3OD): δ 6.97 (H-2’), 6.85 (H-6’’), 
6.82 (H-5’), 6.80 (H-8), 5.93 (H-6), 5.92 (H-2), 
5.89 (H-3) 
 
13C NMR (CD3OD): δ 196.9 (C-4), 167.4 (H-7) 
163.9 (C-5”), 163.1 (C-9), 145.7 (C-4’), 144.9 (C-
3'), 128.4 (C-1’), 119.5 (C-6'), 114.6 (C-5'), 114.4 
(C-2’), 100.4 (C-10), 95.9 (C-6), 94.9 (C-8), 83.8 




1H NMR (CD3OD): δ 6.39 (H-2’), 6.38 (H-6’’), 
6.20 (H-8), 6.19 (H-6), 5.21 (H-1"), 3.89-3.32 
(glucose) 
13C NMR (CD3OD): δ 177.96 (C-4), 164.71 (H-
7) 161.00 (C-5), 157.25 (C-9), 156.94 (C-2), 
144.96 (C-3’, 5' ), 136.73 (C-4'), 134.59 (C-2), 
120,27 (C-1'), 110.00 (1"), 108.55 (C-2', 6'), 
104.17 (C-10), 98.50 (C-6), 93.28 (C-8),  75.8-
60.54 (glucose). 
   
Epicatechin (4) 
 
1H NMR (CD3OD): δ 4.89 (H-2), 4.18 (H-2), 
2.84, 2.76 (H-4a and 4b), 5.92 (H-6), 5.95 (H-8), 
6.98 (H-2'), 6.75 (5'), 6.80 (6') 
 
13C NMR (CD3OD): δ 78.48 (C-2), 66.09 (C-3), 
27.87 (C-4), 156.2 (C-5), 95.00 (C-6), 156.6(C-
7), 94.49 (C-8), 156.2 (C-9), 98.68 (C-10), 
130.88 (C-1'), 113.92 (C-2'), 144.55 (C-3'), 




1H NMR (CD3OD): δ 4.58 (H-2), 4.01 (H-3), 
2.87, 2.83 (H-4a and 4b), 5.87 (H-6), 5.93 (H-8), 
6.85 (H-2'), 6.74 (5'), 6.78 (6') 
 
13C NMR (CD3OD): δ 81.45 (C-2), 67.42 (C-3), 
27.12 (C-4), 155.51 (C-5), 94.11 (C-6), 156.43 
(C-7), 94.11 (C-8), 156.18 (C-9), 99.43 (C-10), 
130.81 (C-1'), 113.86 (C-2'), 144.85 (C-3'), 
144.83 (C-4'), 114.70 (C-5'), 118.85 (C-6'). 
 
Based on co-TLC, 1H and 13C-NMR, and direct 
comparison with published data, compounds 1, 
2, 3, 4, and 5 were identified as gallocatechin, 
taxifolin, myricetin-3-O-β-glucoside, catechin, 
and epicatechin, respectively (Fig 4) [15-17]. The 
proposed structure was confirmed by comparison 





   Figure 4:  Chemical structures of the isolated compounds 
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All over the world, the number of patients with 
AD is often increasing. Furthermore, AD is 
becoming one of the main challenges for many 
societies worldwide. AD is characterized by 
memory loss, language deterioration, poor 
judgment, impaired visuospatial skills, and other 
problems [18]. It was reported that risk factors of 
AD include biological, genetic, and environmental 
factors, and each category can contribute to 
impairment of normal central nervous system 
(CNS) regulation and function. 
 
Links between risk factors and the development 
of neuroinflammation are diverse and include 
several complex connections that help to turn on 
the AD developmental cascade. Once this 
cascade of events is initiated, the process of 
neuroinflammation can become overactivated, 
resulting in further cellular damage and loss of 
neuronal function [19]. In addition, 
neuroinflammation is associated with the 
formation of amyloid-β plaques and 
neurofibrillary tangles: the pathological hallmarks 
of AD. Treatments based on this knowledge 
(aimed at limiting the onset of 
neuroinflammation) may arrest or even reverse 
the development of the disease [20]. 
 
COX-2 binds to arachidonic acid and releases 
metabolites that induce pain and inflammatory 
responses. Consequently, the development of 
potent COX-2 inhibitors to relieve pain and to 
treat inflammation-related diseases is a serious 
challenge for researchers studying prevention or 
treatment of inflammatory diseases. Recent 
studies showed that progression of AD is 
reduced among some users of NSAIDs [21]. 
Furthermore, chronic treatment with selective 
COX-2 inhibitors may slow the progression of AD 
without causing gastrointestinal damage [21]. 
Therefore, selective COX-2 inhibitors have been 
developed as a new generation of NSAIDs with 
diminished gastrointestinal (GI) side effects [22]. 
It is evident from our results that R. tripartita 
extract fractions may serve as nonsteroidal anti-
inflammatory agents because they significantly 
inhibited COX-2 dose dependently, with a weak 
inhibitory effect on COX-1. 
 
The loss of cholinergic cells, mainly in the basal 
forebrain, is accompanied by a loss of the 
neurotransmitter acetylcholine. A widely 
accepted strategy for AD treatment is the use of 
cholinesterase inhibitors [20]. 
Acetylcholinesterase inhibitors are the major 
class of drugs approved for AD and provide 
symptomatic relief and improve cognitive function 
[23]. R. tripartita extract fractions significantly 
inhibited acetylcholinesterase in a concentration-
dependent manner. Subfraction RT2-III, fraction 
RT2, fraction RT4, and subfraction RT2-I were 
the most potent acetylcholinesterase inhibitors. 
 
Oxidative stress is characterized by the initial 
feature of defenseless neurons in AD. Exposure 
to oxidative stress induces accumulation of 
intracellular ROS, which in turn cause cell 
damage in the form of oxidation of proteins, 
lipids, and DNA. Elevated ROS levels are 
associated with increased deposition of amyloid-
β and formation of neurofibrillary plaques: 
hallmarks of the AD brain. When upregulated 
ROS overwhelm the basal level of cellular 
protective mechanisms, oxidative damage and 
cell death will follow. As a result, substances that 
can diminish oxidative stress are considered 
possible prophylactic or therapeutic agents for 
neurodegenerative diseases such as AD [24]. 
 
Astrocytes play an essential role in antioxidant 
defense mechanisms of the CNS, which is 
especially vulnerable to ROS because the CNS 
is a highly oxygenated organ that consumes 20 
% of whole-body oxygen [25]. Nonetheless, it 
may be postulated that the imbalance between 
the production of reactive species and the 
antioxidant defense observed in the periphery 
(e.g., red blood cells), is even more serious in 
brain tissue. All the tested samples showed 
potent radical scavenging against various radical 





It is evident from our results that R. tripartita 
extract subfraction RT2-III and fractions RT2 and 
RT4 are potent and selective inhibitors of COX-2 
(rather than COX-1), with strong inhibition of 
acetylcholinesterase; the latter activity 
accompanied the radical-scavenging effects. 
These activities indicate that components of 
subfraction RT2-III and fractions RT2 and RT4 
can serve as natural prophylactic agents against 
neuroinflammatory diseases like AD and 
dementia, and they can be recommended for 
further studies to prove their effects as natural 
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